Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darell D Bigner

Showing results (31-40 of 242) with videos related to

Pageof 25
Sort By:
Seminars in Immunology|June 10, 2008
Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant gliomaJohn H Sampson, Gary E Archer, Duane A Mitchell, et al.
Toxins|November 10, 2011
Monitoring radiographic brain tumor progressionAnkit I Mehta, Charles W Kanaly, Allan H Friedman, et al.
Cancer Immunology, Immunotherapy : CII|February 28, 2002
Generation of anti-idiotypic reagents in the EGFRvIII tumor-associated antigen systemCarol J Wikstrand, Vanessa R Cole, Laura E Crotty, et al.
Nuclear Medicine and Biology|October 7, 2004
Evaluation of an internalizing monoclonal antibody labeled using N-succinimidyl 3-[131I]iodo-4-phosphonomethylbenzoate ([131I]SIPMB), a negatively charged substituent bearing acylation agentSriram Shankar, Ganesan Vaidyanathan, Donna J Affleck, et al.
The Journal of Biological Chemistry|October 3, 2015
Phosphorylation of Glutathione S-Transferase P1 (GSTP1) by Epidermal Growth Factor Receptor (EGFR) Promotes Formation of the GSTP1-c-Jun N-terminal kinase (JNK) Complex and Suppresses JNK Downstream Signaling and Apoptosis in Brain Tumor CellsTatsunori Okamura, Gamil Antoun, Stephen T Keir, et al.
Oncoimmunology|January 30, 2014
Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibodyBryan D Choi, Patrick C Gedeon, Luis Sanchez-Perez, et al.
Journal of Neuro-Oncology|October 23, 2012
Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine modelStephen T Keir, Henry S Friedman, David A Reardon, et al.
Biochemical and Biophysical Research Communications|October 13, 2009
A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutationYukinari Kato, Genglin Jin, Chien-Tsun Kuan, et al.
Cancer Management and Research|June 7, 2018
Elevated expression of podoplanin and its clinicopathological, prognostic, and therapeutic values in squamous non-small cell lung cancerLiyi Xie, Chen Lin, Qingfu Zhang, et al.
Journal of Biomedical Research|April 5, 2013
Decoupling of DNA damage response signaling from DNA damages underlies temozolomide resistance in glioblastoma cellsBo Cui, Stewart P Johnson, Nancy Bullock, et al.
Pageof 25

Showing results (31-40 of 242) with videos related to

Sort By:
Pageof 25
Seminars in Immunology|June 10, 2008
Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant gliomaJohn H Sampson, Gary E Archer, Duane A Mitchell, et al.
Toxins|November 10, 2011
Monitoring radiographic brain tumor progressionAnkit I Mehta, Charles W Kanaly, Allan H Friedman, et al.
Cancer Immunology, Immunotherapy : CII|February 28, 2002
Generation of anti-idiotypic reagents in the EGFRvIII tumor-associated antigen systemCarol J Wikstrand, Vanessa R Cole, Laura E Crotty, et al.
Nuclear Medicine and Biology|October 7, 2004
Evaluation of an internalizing monoclonal antibody labeled using N-succinimidyl 3-[131I]iodo-4-phosphonomethylbenzoate ([131I]SIPMB), a negatively charged substituent bearing acylation agentSriram Shankar, Ganesan Vaidyanathan, Donna J Affleck, et al.
The Journal of Biological Chemistry|October 3, 2015
Phosphorylation of Glutathione S-Transferase P1 (GSTP1) by Epidermal Growth Factor Receptor (EGFR) Promotes Formation of the GSTP1-c-Jun N-terminal kinase (JNK) Complex and Suppresses JNK Downstream Signaling and Apoptosis in Brain Tumor CellsTatsunori Okamura, Gamil Antoun, Stephen T Keir, et al.
Oncoimmunology|January 30, 2014
Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibodyBryan D Choi, Patrick C Gedeon, Luis Sanchez-Perez, et al.
Journal of Neuro-Oncology|October 23, 2012
Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine modelStephen T Keir, Henry S Friedman, David A Reardon, et al.
Biochemical and Biophysical Research Communications|October 13, 2009
A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutationYukinari Kato, Genglin Jin, Chien-Tsun Kuan, et al.
Cancer Management and Research|June 7, 2018
Elevated expression of podoplanin and its clinicopathological, prognostic, and therapeutic values in squamous non-small cell lung cancerLiyi Xie, Chen Lin, Qingfu Zhang, et al.
Journal of Biomedical Research|April 5, 2013
Decoupling of DNA damage response signaling from DNA damages underlies temozolomide resistance in glioblastoma cellsBo Cui, Stewart P Johnson, Nancy Bullock, et al.
Pageof 25